DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Tatva Chintan Pharma Chem Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 3 hrs ago·7 Aug 2026, 1:29 pm

Tatva Chin Pharm Chem

Tatva Chintan Pharma Chem Limited has announced that it will hold an analyst and institutional investor meet. The company has informed the stock exchanges about the schedule for this conference call.

This announcement is significant for investors as it provides an opportunity to hear directly from the company's management. Such meetings allow the firm to share its strategic vision, discuss financial performance, and outline future growth plans with the market.

Investors should pay close attention to the guidance provided during the call. Key areas of focus will likely include the company's expansion strategies, product pipeline, and overall market outlook for the sector.